ECO Animal Health Group (LON:EAH) Shares Pass Above 50-Day Moving Average - What's Next?

Key Points

• ECO Animal Health Group's shares surpassed their fifty-day moving average, reaching a high of GBX 75.44 ($1.01), with the last trade at GBX 73.50 ($0.98).
• Shore Capital has reiterated a "buy" rating for the stock, setting a price target of GBX 150 ($2.00).
• Insider David Hallas acquired nearly 30,000 shares at an average cost of GBX 67 ($0.90), showing confidence in the company's future performance.

Shares of ECO Animal Health Group plc (LON:EAH - Get Free Report) passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 66.10 ($0.88) and traded as high as GBX 75.44 ($1.01). ECO Animal Health Group shares last traded at GBX 73.50 ($0.98), with a volume of 55,819 shares.

Wall Street Analyst Weigh In

Separately, Shore Capital reiterated a "buy" rating and issued a GBX 150 ($2.00) price objective on shares of ECO Animal Health Group in a report on Monday, July 14th.

ECO Animal Health Group Trading Up 1.1%

The company has a current ratio of 2.96, a quick ratio of 2.14 and a debt-to-equity ratio of 4.81. The company has a market capitalization of £51.06 million, a price-to-earnings ratio of 48.71 and a beta of -0.05. The company has a fifty day moving average of GBX 66.10 and a 200-day moving average of GBX 61.74.

ECO Animal Health Group (LON:EAH - Get Free Report) last posted its quarterly earnings data on Monday, July 14th. The company reported GBX 2.49 ($0.03) earnings per share (EPS) for the quarter. ECO Animal Health Group had a return on equity of 1.27% and a net margin of 1.17%.

Insiders Place Their Bets

In other ECO Animal Health Group news, insider David Hallas bought 29,897 shares of the firm's stock in a transaction on Tuesday, July 15th. The shares were acquired at an average cost of GBX 67 ($0.90) per share, with a total value of £20,030.99 ($26,757.93). 21.65% of the stock is owned by company insiders.

ECO Animal Health Group Company Profile

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline. Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide. Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.